As of January 2026 KalVista Pharmaceuticals has a market cap of NZ$1.31 Billion. This makes KalVista Pharmaceuticals the world's 6435th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 30th, 2026 the market cap of KalVista Pharmaceuticals was reported to be: